{
    "clinical_study": {
        "@rank": "20060", 
        "arm_group": {
            "arm_group_label": "BOTOX\u00ae", 
            "description": "Patients who receive botulinum toxin Type A (BOTOX\u00ae) treatment for chronic migraine as per local standard of care in clinical practice."
        }, 
        "brief_summary": {
            "textblock": "This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and\n      efficacy of botulinum toxin Type A to treat Chronic Migraine in clinical practice."
        }, 
        "brief_title": "Safety and Efficacy of Botulinum Toxin Type A (BOTOX\u00ae) to Treat Chronic Migraine in Korea", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Migraine Disorders", 
            "Headache"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Headache", 
                "Migraine Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients treated with botulinum toxin Type A for chronic migraine in clinical\n             practice.\n\n        Exclusion Criteria:\n\n          -  None."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients treated with botulinum toxin Type A for chronic migraine in clinical practice."
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976611", 
            "org_study_id": "191622-139"
        }, 
        "intervention": {
            "arm_group_label": "BOTOX\u00ae", 
            "description": "Botulinum toxin Type A treatment for chronic migraine as per local standard of care in clinical practice.", 
            "intervention_name": "botulinum toxin Type A", 
            "intervention_type": "Biological"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins, Type A", 
                "Botulinum Toxins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "clinicaltrials@allergan.com", 
            "last_name": "Allergan Inc."
        }, 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Number of Participants with Adverse Events and Adverse Drug Reactions", 
                "safety_issue": "No", 
                "time_frame": "4 Years"
            }, 
            {
                "measure": "Headache Impact Test-6 (HIT-6) Score Using a 5-Point Scale", 
                "safety_issue": "No", 
                "time_frame": "4 Years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976611"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}